C18orf26, denoting "chromosome 18 open reading frame 26," is a gene that encodes a protein of the same name, situated on chromosome 18. This protein belongs to a category of genes identified through genomic sequencing as having the potential to produce proteins, based on the presence of open reading frames within the DNA sequence.As is common with many ORF-identified proteins, the detailed biological functions of C18orf26 are not well-documented in scientific literature. This lack of detailed information can be attributed to the relative novelty of the protein or the complexity of its function, making it a subject for future research. Proteins like C18orf26 may play roles in cellular processes such as signal transduction, regulation of transcription and translation, protein modification, or other critical cellular functions, but these roles can often only be hypothesized based on sequence analysis and homology.
The protein product of C18orf26 may be involved in specific cellular pathways or possess enzymatic activity that is crucial for various metabolic or regulatory processes. It could interact with other cellular components, such as nucleic acids or proteins, influencing cell behavior or physiology.Expression patterns of C18orf26 could provide insights into its function, with tissue-specific expression suggesting a role in the physiology of particular tissues, while ubiquitous expression might imply a more general cellular role. Variations in the expression or mutation of the gene encoding C18orf26 could be associated with disease processes, making it a potential candidate for biomarker research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
A lysosomotropic agent that inhibits autophagy, potentially affecting p62 turnover and function. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
An autophagy inhibitor that blocks autophagic sequestration, indirectly influencing p62 dynamics. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
A specific inhibitor of vacuolar-type H+-ATPase, affecting autophagosome-lysosome fusion, indirectly impacting p62 activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor, could affect protein degradation pathways and indirectly influence p62 levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, inducing autophagy, which could indirectly impact p62 through autophagic degradation. | ||||||